Drugs / BAY1143572
last change Sep 2016 re-read 3 minutes ago

BAY1143572

Developed for
neoplasm
Investigated by
Bayer

Trials 1

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01938638 Sep 2013 → Aug 2016 neoplasm Bayer Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BAY1143572 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01938638 ↗